Two Sigma Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History

Two Sigma Securities’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$173K	Buy	+11,703	New	+$171K	0.02%	1076
2025 Q4	–	Sell	-11,539	Closed	-$128K	–	1471
2025 Q3	$128K	Sell	11,539 -2,920	-20%	-$31.9K	0.02%	878
2025 Q2	$122K	Sell	14,459 -16,285	-53%	-$131K	0.02%	1018
2025 Q1	$247K	Buy	+30,744	New	+$249K	0.04%	722
2024 Q1	–	Sell	-15,738	Closed	-$141K	–	2967
2023 Q4	$141K	Buy	15,738 +5,084	+48%	+$41.9K	﹤0.01%	2473
2023 Q3	$82.8K	Sell	10,654 -13,313	-56%	-$130K	﹤0.01%	2418
2023 Q2	$232K	Buy	+23,967	New	+$249K	﹤0.01%	2086
2023 Q1	–	Sell	-20,026	Closed	-$86.5K	–	2643
2022 Q4	$86.5K	Buy	+20,026	New	+$116K	﹤0.01%	2088
2017 Q2	–	Sell	-32,652	Closed	-$240K	–	859
2017 Q1	$240K	Buy	+32,652	New	+$151K	0.05%	499

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Securities's AUPH Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 11,703 shares worth $173K. The stake represents 0.02% of the portfolio and ranks #1076 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in AUPH as recently as Q3 2025.

Two Sigma Securities first reported a position in AUPH in Q1 2017 and has held it in 9 quarters since. The position peaked at $247K in Q1 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Two Sigma Securities held 11,703 shares of Aurinia Pharmaceuticals worth $173K as of Q1 2026.
Aurinia Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
Aurinia Pharmaceuticals made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1076 holding.
Two Sigma Securities first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 9 quarters since.
Two Sigma Securities's Aurinia Pharmaceuticals position peaked at $247K in Q1 2025.
259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.